Search for: "By Andrew Pollack" Results 21 - 40 of 86
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
6 Nov 2015, 11:57 am by John Jascob
The director of the SEC’s Division of Enforcement, Andrew Ceresney, was joined by several former enforcement directors for a spirited discussion about recent developments concerning SEC enforcement issues. [read post]
26 Oct 2015, 2:30 pm by Thaddeus Mason Pope, J.D., Ph.D.
Panel 1: Ethics and Healthcare Economics Moderator: Mark Siegler The True Cost of Hepatitis C Therapy (Andrew Aronsohn, The University of Chicago) Ethics of Sustainability (Stacy Lindau, The University of Chicago) Are There Ethical Standards For Health Insurance Companies? [read post]
27 Jul 2015, 6:16 am by Jim Sedor
Board of Elections Drops Fines in 208 Cases” by Jennifer Bogdan for Providence Journal Ethics “Criminal Inquiry Is Sought in Clinton Email Account” by Michael Schmidt and Matt Apuzzo for New York Times “Drug Companies Pushed From Far and Wide to Explain High Prices” by Andrew Pollack for New York Times District of Columbia: “New Details Emerge about Metro Contract That Raised Ethical Questions” by Lori Aratani for Washington Post Hawaii:… [read post]
12 Aug 2014, 7:46 am by Nancy E. Halpern, DVM, Esq.
According to Andrew Pollack, reporting on “Start-Ups on Biotech Drugs for Pets” for the New York Times, “Americans spent nearly $56 billion on pets in 2013,” including the cost of veterinary care. [read post]
18 Apr 2014, 9:35 am
Pollack, Is International Relations Corrosive of International Law? [read post]
6 Dec 2013, 6:29 pm by Colin O'Keefe
Patent Reform Progresses As House Passes Goodlatte Innovation Act – Andrew Baluch and Courtenay Brinckerhoff of Foley & Lardner on the firm’s blog, PharmaPatents For more of the best, check out LXBN, a complete review of the top insight and commentary across the LexBlog Network. [read post]
11 Oct 2013, 6:38 am by admin
Ashmore – @kcashmore1 Jason Augustine – @augustinelaw Brandy Harman Austin @thebrandyaustin, @brandyaustinlaw Steve Autry – @autry13 Kencade Babb – @kencadeb Ann Massey Badmus – @annbadmus Bill Bailey – @bbaileylaw David Bailey – @dabjd Leigh Bailey – @leigh_bailey Trina McReynolds Bailey – @trinamcrey Lindley Bain – @lindleybain Lee Baldwin – @leebaldwin55 Marissa Balius – @marissabalius Katie Bandy – @bandykatherine,… [read post]
11 Oct 2013, 6:38 am by admin
Ashmore – @kcashmore1 Jason Augustine – @augustinelaw Brandy Harman Austin @thebrandyaustin, @brandyaustinlaw Steve Autry – @autry13 Kencade Babb – @kencadeb Ann Massey Badmus – @annbadmus Bill Bailey – @bbaileylaw David Bailey – @dabjd Leigh Bailey – @leigh_bailey Trina McReynolds Bailey – @trinamcrey Lindley Bain – @lindleybain Lee Baldwin – @leebaldwin55 Marissa Balius – @marissabalius Katie Bandy – @bandykatherine,… [read post]
25 Feb 2013, 2:33 pm by Tom Lamb
A February 24, 2013 New York Times article, "Anemia Drug Is Recalled After Allergic Reactions", by reporter Andrew Pollack, provides a concise yet insightful report of this new and still emerging drug safety issue: The F.D.A. said in a news release on Sunday that it had received 19 reports of anaphylaxis, a severe allergic reaction, and that three of the patients had died, while others required prompt medical intervention or hospitalization.... [read post]
18 Feb 2013, 6:11 am by Marissa Miller
Monsanto, in which the Court will consider the application of the doctrine of patent exhaustion to self-replicating technologies; coverage of this case comes from Andrew Pollack of The New York Times, Susan Decker and Jack Kaskey of Bloomberg News, CNBC’s Jane Wells, and Greenwire’s Jeremy Jacobs. [read post]
4 Feb 2013, 6:40 am by Legal Beagle
Further in-depth reports from the Cost of Time survey's authors, Dr John Pollack and Andrew Otterburn, will be published in the February and March editions of the Journal. [read post]
14 Oct 2012, 8:50 am by admin
As Denise Grady, Andrew Pollack and Sabrina Tavernise explained in The Times, these pharmacies fall into a legal no man’s land between the Food and Drug Administration and 50 state pharmacy boards, most of which have little expertise and limited resources to ensure the safety of these products. [read post]
28 Jun 2012, 12:39 pm by Zoe Tillman
" Staff writers Matthew Huisman, Andrew Ramonas, Todd Ruger and Zoe Tillman contributed to this report. [read post]
31 May 2012, 3:35 pm by Mike Scarcella
The Edwards case, Pollack said, was a difficult prosecution that featured solid lawyering on both sides of the courtroom. [read post]
17 May 2012, 9:45 pm by Reproductive Rights
The New York Times: A Stem-Cell-Based Drug Gets Approval in Canada, by Andrew Pollack: In a boost for the field of regenerative medicine, a small biotechnology company has received regulatory approval in Canada for what it says is the first... [read post]
26 Apr 2012, 5:28 am by Frank Pasquale
Notes Pollack: “This isn’t win-win, this is win-win-win-win. [read post]